COVID-19: Ensuring the Quality, Resiliency, and Continuity of Breast Cancer Care During a Pandemic

This comprehensive educational program will improve your knowledge, confidence, and competence in providing optimal care for patients with breast cancer during the COVID-19 pandemic.
Harold J. Burstein, MD, PhD
Hope S. Rugo, MD

ClinicalThought

How can we best use modern treatments and technology to balance the risks of the pandemic with the imperative for providing the best possible care for our patients? Here’s my take.

Hope S. Rugo, MD Released: July 22, 2020

Learn why COVID-19 has complicated management of respiratory symptoms in patients with breast cancer and how oncology professionals can triage patients who present with this symptomology.

Harold J. Burstein, MD, PhD Released: August 17, 2020

As the COVID-19 pandemic continues to affect daily practice, how can we ensure continuity and safety in the care of our patients with advanced breast cancer? Here’s my take.

Hope S. Rugo, MD Released: September 25, 2020

COVID-19 has presented many barriers to conducting clinical trials, but I am optimistic that the end results will improve our long-term efficiency in opening and operating trials and offering new treatment options.

Hope S. Rugo, MD Released: September 28, 2020
Provided by Clinical Care Options, LLC.

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Daiichi Sankyo, Inc.
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue